The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy
Overview
Authors
Affiliations
Context: Central serous chorioretinopathy (CSC) is a severe ocular disease characterized by fluid accumulation under the retina and abnormalities in the underlying vascular layer, the choroid. CSC has a striking prevalence in males of 80% to 90% of total patients. Corticosteroids are the most pronounced extrinsic risk factor for CSC. Choroidal endothelial cells (CECs) are important for the vascular integrity of the choroid, but the effects of corticosteroid effects in these cells are unknown.
Objective: We aimed to reveal the potential steroidal contribution to CSC.
Method: We characterized the expression of the glucocorticoid, mineralocorticoid, and androgen receptor in the human choroid using immunohistochemistry. Using RNA-sequencing, we describe the cortisol response in human CECs derived from 5 male and 5 female postmortem donors.
Results: The glucocorticoid receptor was highly expressed in the human choroid, whereas no to minimal expression of the mineralocorticoid and androgen receptors was observed. The extensive transcriptional response to cortisol in human primary cultured CECs showed interindividual differences but very few sex differences. Several highly regulated genes such as ZBTB16 (log2 fold change males 7.9; females 6.2) provide strong links to choroidal vascular regulation.
Conclusions: The glucocorticoid receptor predominantly mediates the response to cortisol in human CECs. Interindividual differences are an important determinant regarding the cortisol response in human cultured CECs, whereas intrinsic sex differences appear less pronounced. The marked response of particular target genes in endothelial cells to cortisol, such as ZBTB16, warrants further investigation into their potential role in the pathophysiology of CSC and other vascular conditions.
Galuh S, Meijer O, Brinks J, Schlingemann R, Boon C, Verdijk R Invest Ophthalmol Vis Sci. 2024; 65(8):5.
PMID: 38958971 PMC: 11223622. DOI: 10.1167/iovs.65.8.5.
Choroidal arterial abnormality in central serous chorioretinopathy.
Tuuminen R, Jeon S Graefes Arch Clin Exp Ophthalmol. 2024; 262(11):3465-3473.
PMID: 38748212 DOI: 10.1007/s00417-024-06522-w.
Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration.
Ramo J, Abner E, van Dijk E, Wang X, Brinks J, Nikopensius T JAMA Ophthalmol. 2023; 141(5):449-457.
PMID: 37079300 PMC: 10119776. DOI: 10.1001/jamaophthalmol.2023.0706.
Risk of Central Serous Chorioretinopathy in Male Androgen Abusers.
Subhi Y, Windfeld-Mathiasen J, Horwitz A, Horwitz H Ophthalmol Ther. 2023; 12(2):1073-1080.
PMID: 36692812 PMC: 10011293. DOI: 10.1007/s40123-023-00658-4.
Jain M, Mohan S, van Dijk E Taiwan J Ophthalmol. 2023; 12(4):381-393.
PMID: 36660127 PMC: 9843580. DOI: 10.4103/2211-5056.362601.